Acacia Research Corp
NASDAQ:ACTG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (12), the stock would be worth $3.72 (25% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 16 | $4.96 |
0%
|
| Industry Average | 12 | $3.72 |
-25%
|
| Country Average | 21.9 | $6.79 |
+37%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Acacia Research Corp
NASDAQ:ACTG
|
478.5m USD | 16 | 22.1 | |
| UK |
|
Relx PLC
LSE:REL
|
48.2B GBP | 17.2 | 23.3 | |
| UK |
I
|
IHS Markit Ltd
F:0M3
|
37.9B EUR | 60 | 36.5 | |
| CA |
|
Thomson Reuters Corp
TSX:TRI
|
54.7B CAD | 35.5 | 26.9 | |
| IE |
|
Experian PLC
LSE:EXPN
|
24.3B GBP | 22.3 | 24.1 | |
| US |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
26B USD | 9.4 | 28.7 | |
| CH |
|
SGS SA
SIX:SGSN
|
16.4B CHF | 9.9 | 24.6 | |
| US |
|
Equifax Inc
NYSE:EFX
|
20.6B USD | 13.9 | 29.5 | |
| US |
|
Leidos Holdings Inc
NYSE:LDOS
|
18.4B USD | 12.8 | 12.7 | |
| US |
U
|
UL Solutions Inc
NYSE:ULS
|
17.7B USD | 0 | 0 | |
| NL |
|
Wolters Kluwer NV
AEX:WKL
|
14.9B EUR | 7.3 | 11.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.1 |
| Median | 21.9 |
| 70th Percentile | 36.5 |
| Max | 3 188 432.5 |
Other Multiples
Acacia Research Corp
Glance View
Acacia Research Corp. engages in the acquisition, development, and patents technologies through its subsidiaries. The company is headquartered in New York City, New York and currently employs 122 full-time employees. The firm's operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. The firm's operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. The firm's operating subsidiaries own or control the rights to multiple patent portfolios, which include the United States patents and certain foreign counterparts, covering technologies used in a range of industries.
